FHLC Fidelity MSCI Health Care Index ETF
81.92
-0.935 (-1.13%)
Quote as of Oct 13, 2026 15:38 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 82.85 | Day Range | 81.73 – 83.13 |
| 52-Week Range | 67.77 – 85.46 | Volume | 94.63K |
| Avg Volume | 245.29K | AUM | $3.54B (Oct 13, 2026) |
| Expense Ratio | 0.08% | Yield (TTM) | 1.23% |
| NAV | 82.44 | Premium/Discount | -0.64% indicative |
| Inception | Oct 21, 2013 | Holdings | 365 |
| Issuer | Fidelity | Exchange | AMEX |
| Category | Healthcare | Index Tracked | Not stated in source data |
| CUSIP | 316092600 | ISIN | US3160926008 |
| Management | Not stated in source data | ||
About this ETF
Seeks to achieve investment results that correspond to the MSCI USA IMI Health Care Index.
Description from the fund data provider · profile as of Oct 13, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +3.18% | +5.61% | +16.33% | +11.54% | +21.45% | +10.84% | +5.66% | +9.59% | +9.61% |
| Total return | +3.18% | +5.61% | +16.74% | +12.31% | +22.74% | +12.33% | +7.10% | +11.20% | +11.23% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 12, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.08% | Annual cost of a $10,000 investment | $8.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 13, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 348 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 13.05% | 404.93K | $477.5M |
| 2 | JOHNSON & JOHNSON | JNJ | 8.70% | 1.22M | $318.4M |
| 3 | ABBVIE INC | ABBV | 6.75% | 893.74K | $247.1M |
| 4 | MERCK & CO INC NEW | MRK | 4.97% | 1.25M | $181.9M |
| 5 | UNITEDHEALTH GROUP INC | UNH | 4.76% | 459.39K | $174.2M |
| 6 | THERMO FISHER SCIENTIFIC INC | TMO | 3.38% | 187.99K | $123.7M |
| 7 | AMGEN INC | AMGN | 3.09% | 273.01K | $113.3M |
| 8 | GILEAD SCIENCES INC | GILD | 2.59% | 628.06K | $94.9M |
| 9 | ABBOTT LABORATORIES | ABT | 2.40% | 881.11K | $87.8M |
| 10 | PFIZER INC | PFE | 2.23% | 2.88M | $81.5M |
| 11 | SECURITIES LENDING CF | — | 2.14% | 78.17M | $78.2M |
| 12 | INTUITIVE SURGICAL INC | ISRG | 2.08% | 179.16K | $76.0M |
| 13 | DANAHER CORP | DHR | 1.94% | 322.23K | $70.8M |
| 14 | VERTEX PHARMACEUTICALS INC | VRTX | 1.79% | 128.40K | $65.5M |
| 15 | BRISTOL-MYERS SQUIBB CO | BMY | 1.67% | 1.03M | $61.1M |
| 16 | MEDTRONIC PLC | 0Y6X.L | 1.57% | 647.52K | $57.3M |
| 17 | CVS HEALTH CORP | CVS | 1.52% | 645.44K | $55.6M |
| 18 | MCKESSON CORP | MCK | 1.52% | 59.23K | $55.6M |
| 19 | STRYKER CORP | SYK | 1.32% | 174.54K | $48.4M |
| 20 | ELEVANCE HEALTH INC | ANTM | 1.24% | 109.71K | $45.3M |
| 21 | REGENERON PHARMACEUTICALS INC | REGN | 1.06% | 52.12K | $38.9M |
| 22 | MODERNA INC | MRNA | 1.05% | 170.61K | $38.4M |
| 23 | CIGNA GROUP (THE) | CI | 1.03% | 133.82K | $37.8M |
| 24 | HCA HEALTHCARE INC | HCA | 0.97% | 78.55K | $35.4M |
| 25 | BOSTON SCIENTIFIC CORP | BSX | 0.88% | 751.89K | $32.1M |
| 26 | CENCORA INC | COR | 0.83% | 93.50K | $30.3M |
| 27 | CARDINAL HEALTH INC | CAH | 0.77% | 118.47K | $28.1M |
| 28 | NATERA INC | NTRA | 0.75% | 68.83K | $27.6M |
| 29 | HUMANA INC | HUM | 0.72% | 60.73K | $26.2M |
| 30 | BECTON DICKINSON & CO | BDXA | 0.70% | 139.38K | $25.6M |
| 31 | EDWARDS LIFESCIENCES CORP | EW | 0.68% | 291.27K | $24.8M |
| 32 | AGILENT TECHNOLOGIES INC | A | 0.67% | 142.87K | $24.4M |
| 33 | IQVIA HOLDINGS INC | IQV | 0.60% | 84.43K | $21.9M |
| 34 | VEEVA SYS INC CL A | VEEV | 0.60% | 73.95K | $21.9M |
| 35 | WATERS CORP | WAT | 0.59% | 49.67K | $21.5M |
| 36 | ILLUMINA INC | ILMN | 0.57% | 74.62K | $20.8M |
| 37 | IDEXX LABS INC | IDXX | 0.56% | 39.91K | $20.7M |
| 38 | BIOGEN INC | BIIB | 0.46% | 74.68K | $16.9M |
| 39 | RESMED INC | RMD | 0.46% | 72.96K | $16.8M |
| 40 | DEXCOM INC | DXCM | 0.45% | 195.20K | $16.4M |
| 41 | REVOLUTION MEDICINES INC | RVMD | 0.45% | 86.04K | $16.3M |
| 42 | CENTENE CORP | CNC | 0.45% | 249.79K | $16.3M |
| 43 | ZOETIS INC CL A | ZTS | 0.43% | 212.06K | $15.9M |
| 44 | METTLER-TOLEDO INTL INC | MTD | 0.43% | 10.23K | $15.9M |
| 45 | ALNYLAM PHARMACEUTICALS INC | ALNY | 0.43% | 67.54K | $15.7M |
| 46 | GE HEALTHCARE TECHNOLOGIES INC | GEHC | 0.41% | 230.09K | $15.1M |
| 47 | WEST PHARMACEUTICAL SVCS INC | WST | 0.36% | 35.72K | $13.1M |
| 48 | LABCORP HOLDINGS INC | LH | 0.35% | 41.48K | $12.9M |
| 49 | QUEST DIAGNOSTICS INC | DGX | 0.35% | 55.98K | $12.9M |
| 50 | ROYALTY PHARMA PLC | RPRX | 0.32% | 207.29K | $11.8M |
| 51 | TENET HEALTHCARE CORP | THC | 0.31% | 43.55K | $11.5M |
| 52 | INSMED INC | INSM | 0.29% | 106.86K | $10.8M |
| 53 | UNITED THERAPEUTICS CORP DEL | UTHR | 0.29% | 19.33K | $10.6M |
| 54 | STERIS PLC | STE | 0.29% | 49.27K | $10.6M |
| 55 | VIATRIS INC | VTRS | 0.28% | 589.88K | $10.4M |
| 56 | GUARDANT HEALTH INC | GH | 0.28% | 62.05K | $10.4M |
| 57 | INCYTE CORP | INCY | 0.26% | 85.82K | $9.7M |
| 58 | ROIVANT SCIENCES LTD | — | 0.26% | 263.79K | $9.3M |
| 59 | ZIMMER BIOMET HLDGS INC | ZBH | 0.24% | 98.07K | $8.7M |
| 60 | REVVITY INC | PKI | 0.24% | 56.52K | $8.7M |
| 61 | CHARLES RIVER LABS INTL INC | CRL | 0.20% | 24.34K | $7.3M |
| 62 | MEDPACE HOLDINGS INC | MEDP | 0.19% | 11.54K | $7.1M |
| 63 | EXELIXIS INC | EXEL | 0.19% | 117.56K | $7.0M |
| 64 | NEUROCRINE BIOSCIENCES INC | NBIX | 0.19% | 48.34K | $6.9M |
| 65 | MEDLINE INC | MDLN | 0.19% | 188.56K | $6.8M |
| 66 | HALOZYME THERAPEUTICS INC | HALO | 0.18% | 60.10K | $6.6M |
| 67 | SOLVENTUM CORP | SOLV | 0.18% | 74.49K | $6.5M |
| 68 | JAZZ PHARMA PLC | JAZZ | 0.18% | 29.38K | $6.4M |
| 69 | BAXTER INTL INC | BAX | 0.17% | 261.78K | $6.4M |
| 70 | ENCOMPASS HEALTH CORP | EHC | 0.17% | 50.19K | $6.2M |
| 71 | PENUMBRA INC | PEN | 0.16% | 18.86K | $6.0M |
| 72 | CORCEPT THERAPEUTICS INC | CORT | 0.16% | 48.98K | $5.9M |
| 73 | ELANCO ANIMAL HEALTH INC | ELAN | 0.16% | 252.81K | $5.8M |
| 74 | BIO TECHNE CORP | TECH | 0.16% | 79.27K | $5.7M |
| 75 | STATE STREET 60 DAY MONEY MARK | — | 0.15% | 5.66M | $5.7M |
| 76 | COOPER COMPANIES INC | COO | 0.15% | 98.43K | $5.4M |
| 77 | AVANTOR INC | AVTR | 0.14% | 336.61K | $5.3M |
| 78 | BRIGHTSPRING HLTH SERVICES INC | BTSG | 0.14% | 81.99K | $5.2M |
| 79 | MOLINA HEALTHCARE INC | MOH | 0.14% | 26.46K | $5.2M |
| 80 | REPLIGEN | RGEN | 0.14% | 29.47K | $5.1M |
| 81 | BRIDGEBIO PHARMA INC | BBIO | 0.14% | 76.85K | $5.0M |
| 82 | BIOMARIN PHARMACEUTICAL INC | BMRN | 0.14% | 90.42K | $5.0M |
| 83 | ENSIGN GROUP INC | ENSG | 0.14% | 28.76K | $4.9M |
| 84 | ALIGN TECHNOLOGY INC | ALGN | 0.13% | 34.45K | $4.9M |
| 85 | INSULET CORP | PODD | 0.13% | 34.99K | $4.7M |
| 86 | GLAUKOS CORP | GKOS | 0.13% | 28.23K | $4.7M |
| 87 | TWIST BIOSCIENCE CORP | TWST | 0.13% | 29.14K | $4.7M |
| 88 | UNIVERSAL HEALTH SVCS INC CL B | UHS | 0.12% | 25.61K | $4.5M |
| 89 | VAXCYTE INC | PCVX | 0.12% | 62.42K | $4.5M |
| 90 | 10X GENOMICS INC | TXG | 0.12% | 53.07K | $4.3M |
| 91 | GLOBUS MEDICAL INC | GMED | 0.12% | 57.10K | $4.3M |
| 92 | HENRY SCHEIN INC | HSIC | 0.11% | 48.96K | $4.1M |
| 93 | TG THERAPEUTICS INC | TGTX | 0.11% | 71.62K | $4.0M |
| 94 | HEALTHEQUITY INC | HQY | 0.11% | 42.29K | $3.9M |
| 95 | CYTOKINETICS INC | CYTK | 0.11% | 61.81K | $3.9M |
| 96 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 0.10% | 60.56K | $3.8M |
| 97 | TEMPUS AI INC | TEM | 0.10% | 52.90K | $3.8M |
| 98 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.10% | 26.03K | $3.7M |
| 99 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.10% | 7.62K | $3.6M |
| 100 | IONIS PHARMACEUTICALS INC | IONS | 0.10% | 79.14K | $3.6M |
| 101 | AXSOME THERAPEUTICS INC | AXSM | 0.10% | 20.80K | $3.5M |
| 102 | KRYSTAL BIOTECH INC | KRYS | 0.09% | 10.42K | $3.5M |
| 103 | BIO RAD LABS CL A | BIO | 0.09% | 9.03K | $3.3M |
| 104 | LANTHEUS HLDGS INC | LNTH | 0.09% | 32.90K | $3.3M |
| 105 | CHEMED CORP | CHE | 0.09% | 6.53K | $3.3M |
| 106 | ALKERMES PLC | ALKS | 0.09% | 80.04K | $3.3M |
| 107 | BRUKER CORP | BRKR | 0.09% | 54.18K | $3.2M |
| 108 | HIMS & HERS HEALTH INC | HIMS | 0.09% | 101.51K | $3.1M |
| 109 | PRAXIS PRECISION MEDICINES INC | PRAX | 0.08% | 11.70K | $3.0M |
| 110 | LIGAND PHARMACEUTICALS | LGND | 0.08% | 9.92K | $3.0M |
| 111 | KYMERA THERAPEUTICS INC | KYMR | 0.08% | 25.98K | $2.9M |
| 112 | DAVITA INC | DVA | 0.08% | 16.22K | $2.9M |
| 113 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.08% | 191.91K | $2.8M |
| 114 | TELEFLEX INC | TFX | 0.08% | 22.39K | $2.8M |
| 115 | HAEMONETICS CORP MASS | HAE | 0.07% | 22.99K | $2.7M |
| 116 | GRAIL INC | GRAL | 0.07% | 19.20K | $2.7M |
| 117 | SPYRE THERAPEUTICS INC | SYRE | 0.07% | 30.98K | $2.7M |
| 118 | MERIT MEDICAL SYSTEMS INC | MMSI | 0.07% | 30.07K | $2.6M |
| 119 | SOTERA HEALTH CO | SHC | 0.07% | 140.79K | $2.5M |
| 120 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.07% | 27.94K | $2.5M |
| 121 | RADNET INC | RDNT | 0.07% | 33.81K | $2.4M |
| 122 | PTC THERAPEUTICS INC | PTCT | 0.06% | 35.61K | $2.3M |
| 123 | HINGE HEALTH INC | HNGE | 0.06% | 22.21K | $2.3M |
| 124 | OPTION CARE HEALTH INC | OPCH | 0.06% | 73.46K | $2.3M |
| 125 | CRISPR THERAPEUTICS AG | CRSP | 0.06% | 42.62K | $2.3M |
| 126 | TRAVERE THERAPEUTICS INC | TVTX | 0.06% | 42.50K | $2.2M |
| 127 | CONCENTRA GROUP HLD PARENT INC | CON | 0.06% | 58.51K | $2.2M |
| 128 | INTEGER HOLDINGS CORP | ITGR | 0.06% | 17.12K | $2.2M |
| 129 | DEFINIUM THERAPEUTICS INC | DFTX | 0.06% | 57.04K | $2.1M |
| 130 | LIVANOVA PLC | LIVN | 0.06% | 27.52K | $2.1M |
| 131 | COGENT BIOSCIENCES INC | COGT | 0.06% | 66.94K | $2.1M |
| 132 | IMMUNITYBIO INC | IBRX | 0.05% | 186.26K | $2.0M |
| 133 | ICU MEDICAL INC | ICUI | 0.05% | 11.95K | $1.9M |
| 134 | ENVISTA HOLDINGS CORP | NVST | 0.05% | 81.89K | $1.9M |
| 135 | INDIVIOR PHARMACEUTICALS INC | INDV | 0.05% | 52.37K | $1.9M |
| 136 | MIRUM PHARMACEUTICALS INC | MIRM | 0.05% | 21.70K | $1.9M |
| 137 | VERACYTE INC | VCYT | 0.05% | 40.36K | $1.8M |
| 138 | ORGANON & CO | OGN | 0.05% | 131.88K | $1.8M |
| 139 | DOXIMITY INC | DOCS | 0.05% | 59.50K | $1.8M |
| 140 | IRHYTHM TECHNOLOGIES INC | IRTC | 0.05% | 16.54K | $1.8M |
| 141 | SCHOLAR ROCK HOLDING CORP | SRRK | 0.05% | 40.90K | $1.7M |
| 142 | HEARTFLOW INC | HTFL | 0.05% | 33.79K | $1.7M |
| 143 | WAYSTAR HOLDING CORP | WAY | 0.04% | 60.61K | $1.6M |
| 144 | ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 0.04% | 60.68K | $1.6M |
| 145 | ORUKA THERAPEUTICS INC | ORKA | 0.04% | 19.39K | $1.6M |
| 146 | VIKING THERAPEUTICS INC | VKTX | 0.04% | 55.66K | $1.6M |
| 147 | CG ONCOLOGY INC | CGON | 0.04% | 24.55K | $1.6M |
| 148 | KODIAK SCIENCES INC | KOD | 0.04% | 15.65K | $1.6M |
| 149 | IDEAYA BIOSCIENCES | IDYA | 0.04% | 43.28K | $1.6M |
| 150 | KINIKSA PHARMACEUTICALS INTERN | KNSA | 0.04% | 19.27K | $1.5M |
| 151 | DIANTHUS THERAPEUTICS INC | DNTH | 0.04% | 18.56K | $1.5M |
| 152 | AMNEAL PHARMACEUTICALS INC | AMRX | 0.04% | 76.68K | $1.5M |
| 153 | XENON PHARMACEUTICALS INC | XENE | 0.04% | 41.59K | $1.5M |
| 154 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.04% | 56.76K | $1.5M |
| 155 | ERASCA INC | ERAS | 0.04% | 92.77K | $1.5M |
| 156 | LIFESTANCE HEALTH GROUP INC | LFST | 0.04% | 115.83K | $1.4M |
| 157 | NATIONAL HEALTHCARE CORP | NHC | 0.04% | 6.28K | $1.4M |
| 158 | CAREDX INC | CDNA | 0.04% | 22.01K | $1.4M |
| 159 | CARIS LIFE SCIENCES INC | CAI | 0.04% | 46.44K | $1.4M |
| 160 | ATRICURE INC | ATRC | 0.04% | 24.09K | $1.3M |
| 161 | DENALI THERAPEUTICS INC | DNLI | 0.04% | 68.14K | $1.3M |
| 162 | TRANSMEDICS GROUP INC | TMDX | 0.04% | 16.61K | $1.3M |
| 163 | NEOGEN CORP | NEOG | 0.03% | 105.34K | $1.2M |
| 164 | AMYLYX PHARMACEUTICALS INC | AMLX | 0.03% | 44.35K | $1.2M |
| 165 | CORVEL CORP | CRVL | 0.03% | 15.46K | $1.2M |
| 166 | ACADIA HEALTHCARE CO INC | ACHC | 0.03% | 40.77K | $1.2M |
| 167 | BEAM THERAPEUTICS INC | BEAM | 0.03% | 46.30K | $1.2M |
| 168 | SUPERNUS PHARMACEUTICALS INC | SUPN | 0.03% | 27.64K | $1.2M |
| 169 | SUMMIT THERAPEUTICS INC | SMMT | 0.03% | 66.71K | $1.2M |
| 170 | DYNE THERAPEUTICS INC | DYN | 0.03% | 69.96K | $1.2M |
| 171 | PRESTIGE CONSUMER HEALTHCA INC | PBH | 0.03% | 24.13K | $1.2M |
| 172 | SELLAS LIFE SCIENCES GROUP INC | SLS | 0.03% | 99.43K | $1.2M |
| 173 | ADMA BIOLOGICS INC | ADMA | 0.03% | 111.56K | $1.2M |
| 174 | ACADIA PHARMACEUTICALS INC | ACAD | 0.03% | 58.13K | $1.1M |
| 175 | TANGO THERAPEUTICS INC | TNGX | 0.03% | 47.29K | $1.1M |
| 176 | PEDIATRIX MEDICAL GROUP INC | MD | 0.03% | 41.83K | $1.1M |
| 177 | TARSUS PHARMACEUTICALS INC | TARS | 0.03% | 15.06K | $1.1M |
| 178 | RELAY THERAPEUTICS INC | RLAY | 0.03% | 61.56K | $1.1M |
| 179 | BROOKDALE SENIOR LIVING INC | BKD | 0.03% | 108.16K | $1.1M |
| 180 | UFP TECHNOLOGIES INC | UFPT | 0.03% | 3.77K | $1.1M |
| 181 | ADDUS HOMECARE CORP | ADUS | 0.03% | 9.22K | $1.1M |
| 182 | PERRIGO CO PLC | 0Y5E.L | 0.03% | 69.40K | $1.0M |
| 183 | CELLDEX THERAPEUTICS INC | CLDX | 0.03% | 34.81K | $1.0M |
| 184 | RECURSION PHARMACEUTICALS INC | RXRX | 0.03% | 237.37K | $1.0M |
| 185 | PRIVIA HEALTH GROUP INC | PRVA | 0.03% | 49.47K | $1.0M |
| 186 | NEOGENOMICS INC | NEO | 0.03% | 62.53K | $1.0M |
| 187 | PROGYNY INC | PGNY | 0.03% | 36.60K | $1.0M |
| 188 | IMMUNOVANT INC | IMVT | 0.03% | 33.41K | $1.0M |
| 189 | ARCUS BIOSCIENCES INC | RCUS | 0.03% | 41.36K | $1.0M |
| 190 | ENLIVEN THERAPEUTICS INC | ELVN | 0.03% | 24.52K | $1.0M |
| 191 | CLOVER HEALTH INVESTEMENTS COR | CLOV | 0.03% | 205.93K | $986.4K |
| 192 | VERICEL CORP | VCEL | 0.03% | 24.55K | $984.4K |
| 193 | HARMONY BIOSCIENCES HLDGS INC | HRMY | 0.03% | 24.10K | $970.9K |
| 194 | FORTREA HOLDINGS INC | FTRE | 0.03% | 46.03K | $959.3K |
| 195 | LIQUIDIA CORP | LQDA | 0.03% | 34.84K | $953.9K |
| 196 | PACS GROUP INC | PACS | 0.03% | 22.02K | $953.4K |
| 197 | IMMUNOME INC | IMNM | 0.03% | 48.68K | $951.8K |
| 198 | EDGEWISE THERAPEUTICS INC | EWTX | 0.03% | 24.36K | $951.7K |
| 199 | NOVAVAX INC | NVAX | 0.03% | 73.13K | $932.4K |
| 200 | AXOGEN INC | AXGN | 0.03% | 25.71K | $928.8K |
| 201 | AGIOS PHARMACEUTICALS INC | AGIO | 0.02% | 28.59K | $909.5K |
| 202 | VERADERMICS INC | MANE | 0.02% | 6.88K | $900.3K |
| 203 | AURINIA PHARMACEUTICALS INC | AUPH | 0.02% | 53.78K | $895.5K |
| 204 | XERIS BIOPHARMA HOLDINGS INC | XERS | 0.02% | 85.44K | $895.5K |
| 205 | SAREPTA THERAPEUTICS INC | SRPT | 0.02% | 49.86K | $890.0K |
| 206 | SCHRODINGER INC | SDGR | 0.02% | 32.55K | $888.0K |
| 207 | DENTSPLY SIRONA INC | XRAY | 0.02% | 100.53K | $887.7K |
| 208 | INTELLIA THERAPEUTICS INC | NTLA | 0.02% | 67.68K | $884.6K |
| 209 | CELCUITY INC | CELC | 0.02% | 12.97K | $880.9K |
| 210 | ASTRANA HEALTH INC | AMEH | 0.02% | 22.89K | $859.3K |
| 211 | LEMAITRE VASCULAR INC | LMAT | 0.02% | 10.38K | $837.6K |
| 212 | INSPIRE MEDICAL SYSTEMS INC | INSP | 0.02% | 12.04K | $829.6K |
| 213 | AZENTA INC | BRKS | 0.02% | 21.60K | $814.8K |
| 214 | OMNICELL INC | OMCL | 0.02% | 22.39K | $802.1K |
| 215 | VIR BIOTECHNOLOGY INC | VIR | 0.02% | 68.23K | $798.3K |
| 216 | BIOCRYST PHARMACEUTICALS INC | BCRX | 0.02% | 93.18K | $796.7K |
| 217 | BUTTERFLY NETWORK INC A | BFLY | 0.02% | 94.47K | $779.4K |
| 218 | PRECIGEN INC | PGEN | 0.02% | 98.38K | $768.4K |
| 219 | BIOHAVEN LTD | BHVN | 0.02% | 62.73K | $757.8K |
| 220 | INNOVIVA INC | INVA | 0.02% | 35.66K | $756.3K |
| 221 | NOVOCURE LTD | NVCR | 0.02% | 51.74K | $754.3K |
| 222 | ALIGNMENT HEALTHCARE INC | ALHC | 0.02% | 99.57K | $751.3K |
| 223 | PALVELLA THERAPEUTICS INC | PVLA | 0.02% | 5.41K | $750.7K |
| 224 | ABSCI CORP | ABSI | 0.02% | 72.81K | $739.7K |
| 225 | VIRIDIAN THERAPEUTICS INC | VRDN | 0.02% | 39.06K | $729.0K |
| 226 | UROGEN PHARMA LTD | URGN | 0.02% | 19.73K | $726.5K |
| 227 | AMN HEALTHCARE SERVICES INC | AMN | 0.02% | 19.76K | $721.7K |
| 228 | MINERALYS THERAPEUTICS INC | MLYS | 0.02% | 30.10K | $703.3K |
| 229 | NEWAMSTERDAM PHARMA COMPANY NV | NAMS | 0.02% | 32.53K | $701.8K |
| 230 | NURIX THERAPEUTICS INC | NRIX | 0.02% | 31.33K | $700.3K |
| 231 | CONMED CORP | CNMD | 0.02% | 15.62K | $694.0K |
| 232 | ULTRAGENYX PHARMA INC | RARE | 0.02% | 44.80K | $693.5K |
| 233 | PACIRA BIOSCIENCES INC | PCRX | 0.02% | 18.91K | $686.5K |
| 234 | OMEROS CORP | OMER | 0.02% | 34.57K | $685.5K |
| 235 | ALPHATEC HOLDINGS INC | ATEC | 0.02% | 63.26K | $675.0K |
| 236 | ETON PHARMACEUTICALS INC | ETON | 0.02% | 12.14K | $670.0K |
| 237 | PENNANT GROUP INC | PNTG | 0.02% | 16.79K | $666.9K |
| 238 | DISC MEDICINE INC | IRON | 0.02% | 10.62K | $659.4K |
| 239 | ANI PHARMACEUTICALS INC | ANIP | 0.02% | 8.90K | $657.5K |
| 240 | SYNDAX PHARMACEUTICALS INC | SNDX | 0.02% | 38.09K | $647.2K |
| 241 | VERA THERAPEUTICS INC | VERA | 0.02% | 21.61K | $645.8K |
| 242 | US PHYSICAL THERAPY INC | USPH | 0.02% | 7.59K | $643.1K |
| 243 | NEKTAR THERAPEUTICS | NKTR | 0.02% | 14.96K | $615.7K |
| 244 | NUVATION BIO INC | NUVB | 0.02% | 122.60K | $613.0K |
| 245 | TREVI THERAPEUTICS INC | TRVI | 0.02% | 46.07K | $607.7K |
| 246 | GENEDX HOLDINGS CORP-A | WGS | 0.02% | 9.00K | $606.0K |
| 247 | XENCOR INC | XNCR | 0.02% | 23.99K | $590.8K |
| 248 | UNIQURE N.V. | 0EE0.L | 0.02% | 26.06K | $588.7K |
| 249 | MBX BIOSCIENCES INC | MBX | 0.02% | 11.02K | $586.5K |
| 250 | OCULAR THERAPEUTIX INC | OCUL | 0.02% | 76.01K | $573.1K |
| 251 | GUARDIAN PHARMACY SERVICES INC | GRDN | 0.02% | 13.86K | $572.3K |
| 252 | ESTABLISHMENT LABS HOLDINGS | ESTA | 0.02% | 9.23K | $569.5K |
| 253 | SURGERY PARTNERS INC | SGRY | 0.02% | 40.68K | $565.0K |
| 254 | TANDEM DIABETES CARE INC | TNDM | 0.02% | 34.51K | $556.0K |
| 255 | AVEANNA HEALTHCARE HLDGS INC | AVAH | 0.01% | 44.06K | $539.8K |
| 256 | ZYMEWORKS DELAWARE INC | ZYME | 0.01% | 20.69K | $533.5K |
| 257 | TELADOC HEALTH INC | TDOC | 0.01% | 88.76K | $512.1K |
| 258 | NUTEX HEALTH INC | NUTX | 0.01% | 2.48K | $511.4K |
| 259 | PROCEPT BIOROBOTICS CORP | PRCT | 0.01% | 27.75K | $510.6K |
| 260 | ENOVIS CORP | ENOV | 0.01% | 28.68K | $507.4K |
| 261 | SONIDA SENIOR LIVING INC | SNDA | 0.01% | 14.36K | $505.9K |
| 262 | CERTARA INC | CERT | 0.01% | 55.06K | $502.7K |
| 263 | CASTLE BIOSCIENCES INC | CSTL | 0.01% | 14.31K | $492.4K |
| 264 | STOKE THERAPEUTICS INC | STOK | 0.01% | 19.80K | $489.9K |
| 265 | MANNKIND CORP | MNKD | 0.01% | 148.55K | $488.7K |
| 266 | HARROW INC | HROW | 0.01% | 16.06K | $471.6K |
| 267 | QUIDELORTHO CORP | QDEL | 0.01% | 34.65K | $465.0K |
| 268 | INTEGRA LIFESCIENCES HLDS CORP | IART | 0.01% | 34.57K | $464.6K |
| 269 | PULSE BIOSCIENCES INC | PLSE | 0.01% | 8.61K | $463.3K |
| 270 | ARTIVION INC | AORT | 0.01% | 21.71K | $461.5K |
| 271 | PERSONALIS INC | PSNL | 0.01% | 28.34K | $453.5K |
| 272 | OMADA HEALTH INC | OMDA | 0.01% | 20.30K | $437.4K |
| 273 | AGILON HEALTH INC | AGL | 0.01% | 5.28K | $434.7K |
| 274 | AMPHASTAR PHARMACEUTICALS INC | AMPH | 0.01% | 16.29K | $433.7K |
| 275 | PHIBRO ANIMAL HEALTH CORP CL A | PAHC | 0.01% | 11.15K | $426.9K |
| 276 | RAPPORT THERAPEUTICS INC | RAPP | 0.01% | 13.91K | $426.4K |
| 277 | TAYSHA GENE THERAPIES INC | TSHA | 0.01% | 93.03K | $417.7K |
| 278 | ANAPTYSBIO INC | ANAB | 0.01% | 8.98K | $412.5K |
| 279 | MARAVAI LIFESCIENCES HLDGS INC | MRVI | 0.01% | 54.08K | $402.4K |
| 280 | HEALTHSTREAM INC | HSTM | 0.01% | 12.12K | $401.4K |
| 281 | SI-BONE INC | SIBN | 0.01% | 20.63K | $399.5K |
| 282 | KURA ONCOLOGY INC | KURA | 0.01% | 37.66K | $399.1K |
| 283 | JANUX THERAPEUTICS INC | JANX | 0.01% | 21.57K | $396.7K |
| 284 | FIRST TRACKS BIOTHERAPEUTICS I | TRAX | 0.01% | 12.30K | $391.8K |
| 285 | ARDELYX INC | ARDX | 0.01% | 115.92K | $380.2K |
| 286 | IRADIMED CORP | IRMD | 0.01% | 4.24K | $370.4K |
| 287 | ZENAS BIOPHARMA INC | ZBIO | 0.01% | 13.39K | $365.0K |
| 288 | COLLEGIUM PHARMACEUTICAL INC | COLL | 0.01% | 16.07K | $355.0K |
| 289 | INHIBRX BIOSCIENCES INC | INBX | 0.01% | 3.64K | $345.9K |
| 290 | CORVUS PHARMACEUTICALS | CRVS | 0.01% | 31.84K | $335.0K |
| 291 | SEPTERNA INC | SEPN | 0.01% | 8.56K | $328.6K |
| 292 | AVALO THERAPEUTICS INC | AVTX | 0.01% | 23.93K | $326.6K |
| 293 | STAAR SURGICAL CO NEW | STAA | 0.01% | 15.02K | $325.4K |
| 294 | KESTRA MEDICAL TECHNOLOGIES IN | KMTS | 0.01% | 12.06K | $325.3K |
| 295 | MAZE THERAPEUTICS INC | MAZE | 0.01% | 11.84K | $321.1K |
| 296 | LB PHARMACEUTICALS INC | LBRX | 0.01% | 8.60K | $319.9K |
| 297 | GERON CORP | GERN | 0.01% | 252.47K | $309.3K |
| 298 | JADE BIOSCIENCES INC | JBIO | 0.01% | 21.04K | $302.8K |
| 299 | MEIRAGTX HOLDINGS PLC | MGTX | 0.01% | 28.09K | $300.3K |
| 300 | CULLINAN ONCOLOGY INC | CGEM | 0.01% | 19.14K | $297.3K |
| 301 | PHREESIA INC | PHR | 0.01% | 26.40K | $285.4K |
| 302 | CORMEDIX INC | CRMD | 0.01% | 37.89K | $279.6K |
| 303 | DAMORA THERAPEUTICS INC | DMRA | 0.01% | 13.23K | $279.0K |
| 304 | OPKO HEALTH INC | OPK | 0.01% | 191.79K | $264.7K |
| 305 | ORIC PHARMACEUTICALS INC | ORIC | 0.01% | 21.96K | $263.3K |
| 306 | ALTO NEUROSCIENCE INC | ANRO | 0.01% | 10.80K | $263.2K |
| 307 | ADAPTHEALTH CORP | AHCO | 0.01% | 42.91K | $260.0K |
| 308 | ARBUTUS BIOPHARMA CORP | ABUS | 0.01% | 60.89K | $257.0K |
| 309 | TYRA BIOSCIENCES INC | TYRA | 0.01% | 12.76K | $254.5K |
| 310 | MONTE ROSA THERAPEUTICS INC | GLUE | 0.01% | 24.24K | $249.7K |
| 311 | HEMAB THERAPEUTICS HOLDINGS IN | COAG | 0.01% | 7.69K | $243.2K |
| 312 | GINKGO BIOWORKS HOLDINGS INC | DNA | 0.01% | 18.60K | $241.8K |
| 313 | ANNEXON INC | ANNX | 0.01% | 59.85K | $240.6K |
| 314 | SANA BIOTECHNOLOGY INC | SANA | 0.01% | 85.42K | $238.3K |
| 315 | BICARA THERAPEUTICS INC | BCAX | 0.01% | 13.61K | $238.2K |
| 316 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 0.01% | 21.96K | $237.6K |
| 317 | CYTOMX THERAPEUTICS INC | CTMX | 0.01% | 91.44K | $235.0K |
| 318 | SAVARA INC | SVRA | 0.01% | 46.57K | $229.1K |
| 319 | WAVE LIFE SCIENCES INC | WVE | 0.01% | 65.62K | $227.0K |
| 320 | ARRIVENT BIOPHARMA INC | AVBP | 0.01% | 13.53K | $226.4K |
| 321 | VOR BIOPHARMA INC | VOR | 0.01% | 10.94K | $217.8K |
| 322 | TILRAY BRANDS INC CL 2 | TLRY | 0.01% | 60.99K | $215.9K |
| 323 | ALUMIS INC | ALMS | 0.01% | 29.63K | $212.1K |
| 324 | PRIME MEDICINE INC | PRME | 0.01% | 52.95K | $211.3K |
| 325 | ARVINAS INC | ARVN | 0.01% | 27.43K | $209.6K |
| 326 | KAILERA THERAPEUTICS INC | KLRA | 0.01% | 18.00K | $209.0K |
| 327 | OLEMA PHARMACEUTICALS INC | OLMA | 0.01% | 26.44K | $206.8K |
| 328 | AVALYN PHARMA INC | AVLN | 0.01% | 7.85K | $202.3K |
| 329 | CAPRICOR THERAPEUTICS INC | CAPR | 0.00% | 23.36K | $182.9K |
| 330 | LEXICON PHARMACEUTICALS INC | LXRX | 0.00% | 106.68K | $179.2K |
| 331 | PHATHOM PHARMACEUTICALS INC | PHAT | 0.00% | 24.05K | $174.4K |
| 332 | XAV HEALTH CARE FT DEC26 IXCZ6 | — | 0.00% | 3.90K | $171.7K |
| 333 | GOODRX HOLDINGS INC | GDRX | 0.00% | 45.85K | $157.3K |
| 334 | EYEPOINT PHARMACEUTICALS INC | EYPT | 0.00% | 37.35K | $127.0K |
| 335 | US DOLLAR | — | 0.00% | 113.68K | $113.7K |
| 336 | ARS PHARMACEUTICALS INC | SPRY | 0.00% | 23.82K | $100.8K |
| 337 | BIOAGE LABS INC | BIOA | 0.00% | 15.75K | $99.8K |
| 338 | SIONNA THERAPEUTICS INC | SION | 0.00% | 6.84K | $33.5K |
| 339 | AKOUOS INC CVR | — | 0.00% | 11.86K | $1.8K |
| 340 | OMNIAB INC - 12.5 EARNOUT | — | 0.00% | 3.33K | $1.3K |
| 341 | TPG INC CVR RT | — | 0.00% | 100.79K | $1.0K |
| 342 | OMNIAB INC - 15.00 EARNOUT | — | 0.00% | 3.33K | $867.10 |
| 343 | THERAVANCE BIOPHARMA INC CVR | — | 0.00% | 18.68K | $560.46 |
| 344 | NOVO-NORDISK AS CVR | — | 0.00% | 22.34K | $0.22 |
| 345 | NOVARTIS AG CVR RT | — | 0.00% | 24.22K | $0.29 |
| 346 | GILEAD SCIENCES INC CVR RT | — | 0.00% | 12.69K | $0.13 |
| 347 | E-MINI RUSS 2000 F DEC26 RTYZ6 | — | 0.00% | 200 | -$14.7K |
| 348 | NET OTHER ASSETS | — | -2.09% | 0 | -$76.4M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.23% | Paid (last 12 months) | $1.0180 |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Sep 18, 2026 | Last payment | $0.2540 (Sep 22, 2026) |
| Growth 1Y | -0.49% | Growth 3Y / 5Y (ann.) | +5.21% / +4.73% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Sep 18, 2026 | Sep 18, 2026 | Sep 22, 2026 | $0.2540 |
| Jun 18, 2026 | Jun 18, 2026 | Jun 23, 2026 | $0.2630 |
| Mar 20, 2026 | Mar 20, 2026 | Mar 24, 2026 | $0.2290 |
| Dec 19, 2025 | Dec 19, 2025 | Dec 23, 2025 | $0.2720 |
| Sep 19, 2025 | Sep 19, 2025 | Sep 23, 2025 | $0.2560 |
| Jun 20, 2025 | Jun 20, 2025 | Jun 24, 2025 | $0.2570 |
| Mar 21, 2025 | Mar 21, 2025 | Mar 25, 2025 | $0.2520 |
| Dec 20, 2024 | Dec 20, 2024 | Dec 24, 2024 | $0.2580 |
| Sep 20, 2024 | Sep 20, 2024 | Sep 24, 2024 | $0.2500 |
| Jun 21, 2024 | Jun 21, 2024 | Jun 25, 2024 | $0.2420 |
| Mar 15, 2024 | Mar 18, 2024 | Mar 20, 2024 | $0.2380 |
| Dec 15, 2023 | Dec 18, 2023 | Dec 20, 2023 | $0.2240 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 15.25% / 14.79% | Sharpe 1Y / 3Y | 1.33 / 0.65 |
| Max drawdown 1Y / 3Y | -10.38% / -16.88% | Sortino 1Y | 2.20 |
| Beta vs S&P 500 (3Y) | 0.497 | Correlation vs S&P 500 (1Y) | 0.283 |
| Downside deviation 1Y | 9.19% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 13, 2026. Formulas →
Liquidity
| Volume today | 94.63K | Average volume | 245.29K |
| AUM | $3.54B | Premium/Discount | -0.64% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $3.54B → $3.54B |
| 1 Month | -$50.5M | -1.45% | $3.48B → $3.54B |
| 1 Week | -$26.5M | -0.76% | $3.48B → $3.54B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
Official Fund Page ↗
ETF Issuer Website (Fidelity) ↗
Prospectus filings (SEC EDGAR) ↗
Annual / Semiannual reports (SEC EDGAR) ↗
All SEC filings ↗
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for FHLC
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
3 Reasons to Watch Quality International ETF QINT Now ↗
Markets are facing a lot right now, from geopolitical risks to inflationary and monetary pressures. A huge bet on AI, meanwhile, looms over the…
ETF Trends · Oct 13, 12:00 UTC
Tackle CLO Momentum With Actively Managed ETF Exposure ↗
Those who are well-versed in the fixed income market are likely aware of how attractive the collateralized loan obligation (CLO) opportunity set is…
ETF Trends · Oct 13, 11:45 UTC
Fed Hike Puts Bond Investors at a Crossroads ↗
Federal Reserve Chair Kevin Warsh said the central bank would take its cues from the bond market. One bond manager says that plan backfired quickly.…
ETF Trends · Oct 13, 11:30 UTC
Luxxfolio Announces Strategic Investment in LitVM to Support Expansion of Litecoin Ecosystem ↗
Strategic investment reinforces Luxxfolio's Litecoin-first strategy and commitment to supporting infrastructure and innovation across the Litecoin…
Newsfile Corp · Oct 13, 11:28 UTC
The Job Market: Healthier Than You Think ↗
The Fed can stay focused on inflation Despite its recent weak showing, we believe the U.S. labor market remains healthy. Last week's jobs report…
ETF Trends · Oct 13, 11:23 UTC
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban ↗
The Federal Trade Commission said Martin Shkreli is still trading pharmaceutical stocks. The FTC said the "Pharma Bro" continues to do this despite a…
Business Insider · Oct 13, 11:21 UTC
All news for FHLC →
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.